Dennis Michael Marcus MD

Ophthalmology•Augusta, GA

Retinal Disease

Physician

Join to View Full Profile

3685 Wheeler RdSuite 201Augusta, GA 30909
Phone+1 706-650-0061
Fax+1 706-650-0064

Education & Training

Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1990 - 1993
Hackensack University Medical Center (Palisades)Internship, Transitional Year, 1987 - 1988
Albert Einstein College of MedicineClass of 1987

Certifications & Licensure

GA State Medical License 1994 - 2027
NY State Medical License 2023 - 2027
FL State Medical License 2023 - 2026
IL State Medical License 2023 - 2026
MA State Medical License 2023 - 2026
SC State Medical License 1997 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MaximEyes SQL EHR, First Insight Corporation, 2012
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
Completed
Phase 2, Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
COMPLETED
PHASE2
Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy Start of enrollment: 2011 Sep 01
Completed
Phase 1, Phase 2
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
Terminated
Phase 2
Treatment for Presumed Ocular Histoplasmosis Start of enrollment: 2013 Mar 01
Unknown status
Phase 1, Phase 2
Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab Start of enrollment: 2013 Apr 01
Unknown status
Phase 1, Phase 2
Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Completed
Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Start of enrollment: 2014 Mar 01
Unknown status
Phase 4
IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab Start of enrollment: 2015 Jun 01
Completed
Phase 4
A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy Start of enrollment: 2019 Jul 26
Terminated
Phase 1
Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types Start of enrollment: 2020 Oct 15
Completed
Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH Start of enrollment: 2016 Jun 01
Unknown status
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.
Arshad M Khanani, Peter A Campochiaro, Jordan M Graff, Dennis M Marcus, Daniel Miller
JAMA Ophthalmology. 2025-03-06
Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA.
Charles C Wykoff, Diana V Do, W Lloyd Clark, David S Boyer, Dilsher S Dhoot
Ophthalmology. Retina. 2025-01-01
Clinical Performance of Semi-Automated Spectral-Domain Optical Coherence Tomography Angiography.
A Yasin Alibhai, Mary K Durbin, Huiyuan Hou, Srinivas R Sadda, Dennis M Marcus
Journal of Clinical Medicine. 2024-10-22

Press Mentions

Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019